The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma

Non-Hodgkin lymphoma (NHL) is one of the most common causes of cancer-related death in the United States and Europe. Although the outcome of NHL patients has improved over the last years with current therapies, the rate of mortality is still high. A plethora of new drugs is entering clinical develop...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Dias, Joana N.R., Aguiar, Sandra I., Pereira, Diane M., André, Ana S., Gano, Lurdes, Correia, João D.G., Carrapiço, Belmira, Rütgen, Barbara, Malhó, Rui, Peleteiro, Conceição, Goncalves, João, Rodrigues, Cecília M.P., Gil, Solange, Tavares, Luís, Aires-da-Silva, Frederico
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033347/
https://ncbi.nlm.nih.gov/pubmed/29983882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25580
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia